Department of Infection Diseases The Third Affiliated Hospital, Sun Yat-sen University Lai Jing DEFINITION Cholera was defined as Class A communicable diseases in the Law of the people’s Republic of China for Prevention and Control of Communicable Disease. It’s also one of the quarantinable diseases as stipulated by the International Health Regulation (IHRs) . DEFINITION Cholera is an acute infection of intestinal tract caused by Vibrio cholerae. Clinical characteristics: a sudden onset of severe watery diarrhea and vomiting, which lead to dehydration even hypovolemic. Appropriate fluid replacement is the key of treatment and greatly reduces mortality. ETIOLOGY Vibrio cholerae Bacillus: curved, facultative anaerobic, gramnegative motility with a single polar flagellum the erratic movement ETIOLOGY Culture sensitive to low PH tolerant in alkaline condition alkaline peptone water : incubated in stool sample or rectal swab greater sensitivity Antigenic type flagellar H antigen somatic O antigen ETIOLOGY Classification V. cholerae V. cholerae O1* non-O1 V. cholerae (* agglutination in antisera the O1 group antigen) V. cholerae O1 O139 biotype classic biotype EL Tor strain: agglutinate in O group 139 specific antiserum ETIOLOGY Serogroup O1 and O139 strain cause epidemic Virulence: Cholera toxin (CT ) Resistance sensitive to dryness heat sunlight common disinfectants acid, especially gastric acid ETIOLOGY When conditions in the environment such as temperature, salinity and availability of nutrients are suitable, V. cholerae can survive for years in a free-living cycle without the intervention of humans. EPIDEMIOLOGY A disease of antiquity the ancestral home of classic biotype : the Ganges Delta of India subsequently spread to the world seven global pandemics: from 19th century to date the biotype classic : the initial six pandemics EPIDEMIOLOGY biotype EL Tor : recognized first at the EL Tor quarantine station in the Persian Gulf in 1911 biotype EL Tor : 7th pandemic which began in 1961 V.cholerae O139: first designated in India in late 1992 The distribution of cholera in the world EPIDEMIOLOGY Sources of infection patients subclinical patients? carriers? Routes of transmission large numbers of vibrios sources from the voluminous liquid stools contaminated food EPIDEMIOLOGY Contaminated water (river, seawater, wells, etc) flies: as media (contact person to person) the water-borne route EPIDEMIOLOGY Susceptibility of individuals generally susceptible more sensitive: individuals with low gastric production persons of blood group O children under 5 years EPIDEMIOLOGY non-sustain immunity from illness naturally acquired immunity : V. cholerae O1 does not have cross-protect against the O139 strain. EPIDEMIOLOGY Seasonality summer autumn Endemic along the coast or the rivers regions lacking of safe water supplies Cholera cases occured. River overflowed the villages and houses. Drinking water was contaminated. peddlers Most of cholera cases had relation with contaminated food. The nearest epidemic happened in HaiNan providence in China. Cholera in Zimbabwe A new large cholera outbreaks have happened in Zimbabwe since August 2008. Cholera victims lie in a hospital ward in Zimbabwe. until the end of January 2009 exceed 58, 000 cases: reported over 3, 000 people: died The number of cholera deaths continues to increase each day. Cholera is closely linked to inadequate environmental management. lacking of sanitary water people drink contaminated water. Recent interruptions to the water supplies, together with overcrowding PATHOGENESIS Whether the disease develops or not depends on: the host’s non-specific immunity (gastric acidity ) the amount of the bacteria ingested Ingestion of V. cholerae Resistant to gastric acid Colonize small intestine Illness occurs when viable organisms reach the duodenum and jejunum. PATHOGENESIS Active motile vibros penetrate mucous layers and attach to the brush border of the intestinal epithelium where they secrete cholera toxin (CT ). Cholera toxin binds to intestinal cells Chloride channels activated Chloride ion-driven secretion, malabsorption of sodium ion and water Release large quantities of electrolytes & bicarbonates Fluid hypersecretion Diarrhea Dehydration PATHOGENESIS “Watery stool”: non-fecal enriched in water, potassium and bicarbonate no plasma protein or formed elements of the blood no cellular damage or inflammation PATHOLOGY The most prominent pathological findings: dehydration in heart, liver, skin, etc mild pathological changes in small intestine CINICAL MANIFESTATIONS Incubation: several hours ~ 7 days. Clinical course of typical cases: three stages Stage of diarrhea and vomiting Stage of dehydration Stage of reaction and convalescence All signs and symptoms drive from the fluid losses. CINICAL MANIFESTATIONS Stage of diarrhea and vomiting sudden onset with severe diarrhea and vomiting, several times to more than 10 times per day. CINICAL MANIFESTATIONS Fluid loss may be extreme, exceeding 1 liter per hour. rice-water stools: yellowish and watery or clear with flecks of mucus no abdominal pain or tenesmus no fever in general CINICAL MANIFESTATIONS Stage of dehydration acidosis (loss of sodium bicarbonate ) muscle cramps circulatory failure and renal failure ( hypovolumia ) dehydration: thirst hoarse voice; exteme depletion-sunken eyes scaphoid abdomen poor skin turgor loss of skin elasticity Table 1 Clinical findings according to degree of dehydration Finding Mild Dehydration Moderate Dehydration Severe Dehydration Loss of fluid* <5% 5%~10% >10% Mentation Alert Restless Drowsy or comatose Radial pulse rate Normal Rapid Very rapid Stystolic blood pressure Skin elasticity Normal Low Very low Retracts rapidly Normal Retracts slowly Sunken Retracts very slowly Normal Scant oliguria Eyes Urine prouduction Very sunken CINICAL MANIFESTATIONS Stage of reaction and convalescence: recover from the disease if dehydration corrected promptly. pyretic reaction CINICAL MANIFESTATIONS In rare instances cholera sicca shock and death occur before diarrhea appears. COMPLICATIONS Acute renal failure Acute pulmonary edema DIAGNOSIS Tentative diagnosis: clinical manifestations and epidemiologic data Patient develops or dies from severe watery diarrhea and dehydration in an area where cholera is not endemic. Patient develops acute watery diarrhea in an area where there is an epidemic or cholera is endemic. Definitive diagnosis: the isolation of the V.cholerae from stool, vomit or rectal swab DIFFERENTIAL DIAGNOSIS Bacterial food poisonings Gastroenteritis enterotoxigenic E. coli enteropathogenic E. coli shigellosis LABORATORY FINDINGS Stool examinations stool routine test: mucus and WBC dark-field microscopic examination: darting motility of vibrios in fresh wet preparations LABORATORY FINDINGS stool hanging drop examinations and motility inhibition test: The bacteria can be discerned by immobilization with its serotype antiserum. culture:alkaline peptone water or thiosulfate-citrate-bile salt-sucrose (TCBS) agar Opaque flat yellow colonies form on TCBS agar in 18 hours at 37℃. LABORATORY FINDINGS Blood examinations increased RBC, hemoglobin and WBC normal or decreased serum sodium, serum potassium, increased BUN decreased CO2CP Urine test: RBC, WBC, albumin, casts. LABORATORY FINDINGS Specific antibody in immobilization test : epidemiological studies Several other methods: latex agglutination enzyme immunoassay polymerase chain reaction (PCR) TREATMENT Isolation: 6 days after the symptoms disappear before 3 negative stools cultures taken once every other day TREATMENT Fluid replacement The goal: restore the fluid losses start as soon as diarrhea begins two phases: rehydration phase maintenance phase two routes: intravenous fluids, oral fluids TREATMENT Intravenous fluids severe or moderate cases or in shock the main principles: early, rapid and enough infuse of salt solution according to the reaction to the treatment correct of the metabolic acidosis give potassium if patients without oliguria Table 2 The volume of intravenous fluids in first 24 hours Volume of infusion Mild Moderate Severe Dehydration Dehydration Dehydration adult(ml) 3000~4000 4000~8000 8000~12000 child 120~150 (ml/kg) salt solution 60~80 (ml/kg) 150~200 200~250 80~100 100~120 (5: 4: 1 solution: NaCl 5g, NaHCO3 4g, KCl 1g and 50% GS 20 ml in per liter of water. ) TREATMENT Oral fluids mild cases severe cases in which the patient’s condition has improved after giving intravenous fluids TREATMENT Oral rehydration solution (ORS): NaCl 3.5, NaHCO3 2.5, KCl 1.5 and GS 20 in grams per liter of water per liter water The volume in the initial 6 hours: adult 750ml/h; child 15~20ml/kg The total volume is decided as the degree of dehydration and ongoing fluid loss. TREATMENT Antibiotics: reduce the duration of diarrhea decrease excretion of the V. cholerae norfloxacin, doxycycline, berberine or SMZ-TMP Treatment of complications acute renal failure acute pulmonary edema PREVENTION Control of sources of infection The diarrhea clinic need be established. Case must be reported to CDC within 6 hours in towns or within 12 hours in villages. all patients: strictly isolated in wards PROGNOSIS Without treatment, mortality approaches 60 per cent of those affected. Management The clinical type PROGNOSIS The mortality is always in greater among the aged and young children the intemperate and those poorly nourished treatment is not vigorous in the early stage of the disease PREVENTION close contacts medical surveillance for 5 days take SMZ-TMP or norfloxacin for 2 days all carriers detection and treatment PREVENTION Interruption of the routes of transmission correct the water supply and sewage system as a matter of urgency PREVENTION provision of facilities for sanitary disposal of human waste education on good personal hygiene a wide variety of disinfectants are effective: bleaching power, soap adhering to proper food safety practices PREVENTION Increase the immunity of individuals Vaccination: different vaccine strains Once an outbreak has started, WHO does not recommend oral cholera vaccine or parenteral cholera vaccine. The vaccine’s limited efficacy is at least partially due to its failure to induce a local immune response at the intestinal mucosal surface.